Could a nasal spray help Parkinson's? new trial tests insulin and glutathione combo
Disease control
Recruiting now
This phase 2 trial is testing whether a nasal spray containing insulin and glutathione can safely improve symptoms in people with Parkinson's disease. About 56 participants will receive either the active spray or a placebo, added to their usual medications. The study focuses on c…
Phase: PHASE2 • Sponsor: Gateway Institute for Brain Research • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC